← Back to Events
IMMUNOLOGY CONCLUDED
ACRP 2026 Annual
Ultimate destination for clinical research leaders and site teams to connect and drive progress in the clinical trial ecosystem.
Coverage & Analysis
8 articlesLIVE COVERAGE
Apr 26
BREAKING ACRP 2026: Immunology Updates and Clinical Trial Insights
Apr 25 BREAKING ACRP 2026: Immunology Updates - Day 1 Key Takeaways
Apr 25 BREAKING ACRP 2026: Immunology Clinical Research Highlights - Day 1
Apr 24 BREAKING ACRP 2026: Immunology Updates and Clinical Research Trends
Apr 24 BREAKING ACRP 2026: Immunology Updates and Clinical Research Trends
Apr 24 BREAKING ACRP 2026: Immunology Updates & Parexel Hiring Event
🇺🇸 Latest Americas News
All news → May 5 Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas May 5 Neurocrine Biosciences Begins Phase 1 Trial of NBIP-2118 for Obesity Treatment May 5 CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 1b/2a Trial in Steroid-Refractory GVHD